Literature DB >> 28469268

Therapy: Celecoxib reduces risk of ulcer bleeding.

Sarah Onuora.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28469268     DOI： 10.1038/nrrheum.2017.63

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN： 1759-4790            Impact factor:   20.543


× No keyword cloud information.
  1 in total

1.  Gastrointestinal safety of celecoxib versus naproxen in patients with cardiothrombotic diseases and arthritis after upper gastrointestinal bleeding (CONCERN): an industry-independent, double-blind, double-dummy, randomised trial.

Authors:  Francis K L Chan; Jessica Y L Ching; Yee Kit Tse; Kelvin Lam; Grace L H Wong; Siew C Ng; Vivian Lee; Kim W L Au; Pui Kuan Cheong; Bing Y Suen; Heyson Chan; Ka Man Kee; Angeline Lo; Vincent W S Wong; Justin C Y Wu; Moe H Kyaw
Journal:  Lancet       Date:  2017-04-11       Impact factor: 79.321
  1 in total
  2 in total

1.  Uric acid drives intestinal barrier dysfunction through TSPO-mediated NLRP3 inflammasome activation.

Authors:  Qiulan Lv; Daxing Xu; Jinfeng Ma; Yan Wang; Xiaomin Yang; Peng Zhao; Liang Ma; Zhiyuan Li; Wan Yang; Xiu Liu; Guanpin Yang; Shichao Xing
Journal:  Inflamm Res       Date:  2020-10-19       Impact factor: 4.575

2.  The molecular mechanisms of celecoxib in tumor development.

Authors:  Bin Wen; Ying-Ting Wei; Lan-Lan Mu; Guo-Rong Wen; Kui Zhao
Journal:  Medicine (Baltimore)       Date:  2020-10-02       Impact factor: 1.817
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.